Przedsiębiorstwo Produkcyjno-Handlowe Ewa S.A.
Manufacture of pharmaceutical preparations
Overview
Ewa S.A. manufactures pharmaceutical products. The company provides contract manufacturing of medicines, class I and II medical devices, and dietary supplements. It operates under GMP and GDP requirements and also develops R&D activities.
Financials
Revenue history (in m)
From the notes
| Current income tax (CIT due) | $348,924 |
Filing timeliness
Financial statements were filed on time, on average 22 days early. All were audited by a statutory auditor.
- 202503/07/2026
- 202429/05/2025
- 202319/06/2024
- 202204/07/2023
- 202128/06/2022
- 202029/09/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Trademarks
The company holds 1 active trademark registered with the Polish Patent Office. 7 marks have expired or were not registered. The first mark was filed in 1998.
| Mark | Number | Classes | Status | Protected until | |
|---|---|---|---|---|---|
| SWEET'N'CLEAN | Z.494179 | 5, 30 | Protected | Dec 21, 2028 | |
| KANOLDY (word) | Z.427835 | 30 | Expired | – | |
| KANOLD (word) | Z.422522 | 30 | Expired | – | |
| Ewa | Z.357072 | 30 | Expired | – | |
| Ewa | Z.357073 | 30 | Expired | – |
| Mark | Protected until | |
|---|---|---|
| SWEET'N'CLEAN | Dec 21, 2028 | |
| KANOLDY (word) | – | |
| KANOLD (word) | – | |
| Ewa | – | |
| Ewa | – |
Authorized Representatives
Manner of representation
Two members of the management board, or a member of the management board jointly with a commercial proxy.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2003-12-31.
92 1160 2202 0000 0006 3081 1779
13 1160 2202 0000 0006 3081 1649
65 1090 1157 0000 0000 1502 6158
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $409.8K$409,803 |
Buildings and premises | $2.3M$2,270,286 |
MSiG notices
6 notices recorded in the Court and Commercial Gazette (MSiG).
| Publication date | Event | |
|---|---|---|
| Sep 21, 2026 | Shareholders' meeting convened | |
| Sep 1, 2026 | Shareholders' meeting convened | |
| Nov 24, 2025 | Shareholders' meeting convened | |
| Apr 24, 2025 | Shareholders' meeting convened | |
| May 6, 2024 | Shareholders' meeting convened |
Public aid
13 public aid cases recorded, with a total value of $888,487.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Oct 19, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | Starosta Powiatu Krotoszyn | |
| Mar 31, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | Starosta Powiatu Krotoszyn | |
| Aug 17, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2020-07-01 | Support for Przedsiębiorstwo Produkcyjno-Handlowe EWA S.A. through a working capital grant. | $102.5K$102,469 | Operational Programme Smart Growth |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| Waste generation | Inactive |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Natur Produkt Pharma sp. z o.o. | $93,854,070.54 | nppharma.pl | ||
| ICN Polfa Rzeszów S.A. | $85,044,250.03 | icnpolfa.pl | ||
| Wörwag Pharma Operations sp. z o.o. | $46,828,794.87 | woerwagpharma.pl | ||
| Zakłady Farmaceutyczne Colfarm S.A. | $27,692,749.78 | colfarm.pl | ||
| Exim Pharma sp. z o.o. | $24,694,130.27 | eximpharma.eu | ||
| Przedsiębiorstwo Farmaceutyczne Farmapol sp. z o.o. | $21,462,728.43 | farmapol.pl | ||
| Silesian Pharma sp. z o.o. | $20,207,433.45 | silesianpharma.pl | ||
| Biofaktor sp. z o.o. | $10,761,755.73 | biofaktor.pl | ||
| Medicofarma S.A. | $8,530,473.72 | medicofarma.pl | ||
| Elanda Pharma sp. z o.o. | $2,725,664.09 | elanda.pl |
FAQ
Last updated: 2026-10-02